BCL2 and ovarian carcinoma: Consistently, they demonstrated that PGPIPIN also inhibits the primary tumor growth rate in xenograft ovarian cancer model mice in a dose-dependent manner by promoting cell apoptosis through inhibition of BCL2 pathway and caspase-3 activation.